Agile Therapeutics Company

Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women. The company's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.
Industry: Reproductive Health & Contraception
Headquarters: Princeton, New Jersey, United States
Founded Date: 01-01-1997
Employees Number: 11-50
Funding Status: IPO
Investors Number: 11
Total Funding: $233,321,650
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-07-01
Last Funding Type: Post-IPO Equity

Visit Website
info@agiletherapeutics.com
https://www.twitter.com/agilether
Register and Claim Ownership